Welcome to LookChem.com Sign In|Join Free

CAS

  • or

112726-66-6

Post Buying Request

112726-66-6 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 1-[1-(1-Benzothiophen-2-Yl)Cyclohexyl]Piperidine Maleate

    Cas No: 112726-66-6

  • No Data

  • 1 Metric Ton

  • 1 million Metric Ton/Year

  • COLORCOM LTD.
  • Contact Supplier

112726-66-6 Usage

Description

BTCP HCL, also known as Benzothiophenylcyclohexylpiperidine Maleate, is a tertiary amino compound that consists of cyclohexane having piperidin-1-yl and benzothiophen-2-yl groups attached at position 1. It is a potent dopamine re-uptake inhibitor with a behavioral profile different from that of phencyclidine (PCP) and similar to that of cocaine.

Uses

Used in Pharmaceutical Industry:
BTCP HCL is used as a potent dopamine re-uptake/transport inhibitor for its unique behavioral profile, which is different from PCP and other stimulants. This makes it a valuable compound for research and development in the pharmaceutical industry, particularly in the study of dopamine-related disorders and the development of new treatments.
Used in Research and Development:
BTCP HCL is used as a research compound for understanding the mechanisms of dopamine re-uptake inhibition and its potential applications in various neurological and psychiatric conditions. Its distinct behavioral profile compared to PCP and cocaine makes it an important tool in the development of new therapeutic strategies and the study of neurotransmitter systems.

Biological Activity

A potent dopamine re-uptake inhibitor with a behavioral profile different from that of PCP and similar to that of cocaine.

references

[1] vignon j, pinet v, cerruti c, et al. [3h] n-[1-(2-benzo (b) thiophenyl) cycohexyl] piperidine ([3h] btcp): a new phencyclidine analog selective for the dopamine uptake complex[j]. european journal of pharmacology, 1988, 148(3): 427-436.[2] chaudieu i, vignon j, chicheportiche m, et al. role of the aromatic group in the inhibition of phencyclidine binding and dopamine uptake by pcp analogs[j]. pharmacology biochemistry and behavior, 1989, 32(3): 699-705.[3] seeman p. brain dopamine receptors[j]. pharmacological reviews, 1980, 32(3): 229-313.[4] maurice t, vignon j, kamenka j m, et al. in vivo labelling of the mouse dopamine uptake complex with the phencyclidine derivative [3 h] btcp[j]. neuroscience letters, 1989, 101(2): 234-238.

Check Digit Verification of cas no

The CAS Registry Mumber 112726-66-6 includes 9 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 6 digits, 1,1,2,7,2 and 6 respectively; the second part has 2 digits, 6 and 6 respectively.
Calculate Digit Verification of CAS Registry Number 112726-66:
(8*1)+(7*1)+(6*2)+(5*7)+(4*2)+(3*6)+(2*6)+(1*6)=106
106 % 10 = 6
So 112726-66-6 is a valid CAS Registry Number.
InChI:InChI=1/C19H25NS.ClH/c1-5-11-19(12-6-1,20-13-7-2-8-14-20)18-15-16-9-3-4-10-17(16)21-18;/h3-4,9-10,15H,1-2,5-8,11-14H2;1H

112726-66-6 Well-known Company Product Price

  • Brand
  • (Code)Product description
  • CAS number
  • Packaging
  • Price
  • Detail
  • Sigma

  • (B138)  BTCP hydrochloride  

  • 112726-66-6

  • B138-10MG

  • 1,674.27CNY

  • Detail
  • Sigma

  • (B138)  BTCP hydrochloride  

  • 112726-66-6

  • B138-25MG

  • 3,871.53CNY

  • Detail

112726-66-6SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 16, 2017

Revision Date: Aug 16, 2017

1.Identification

1.1 GHS Product identifier

Product name 1-[1-(1-benzothiophen-2-yl)cyclohexyl]piperidine

1.2 Other means of identification

Product number -
Other names BTCP MALEATE

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:112726-66-6 SDS

112726-66-6Synthetic route

2-iodobenzothiophene
36748-89-7

2-iodobenzothiophene

1-piperidinocyclohexylcarbonitrile
3867-15-0

1-piperidinocyclohexylcarbonitrile

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
112726-66-6

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine

Conditions
ConditionsYield
With magnesium 1.) ether, 2.) reflux, 16 h; Yield given. Multistep reaction;
1,5-dibromo-pentane
111-24-0

1,5-dibromo-pentane

1-(2-benzothiophenyl)cyclohexylamine
143603-26-3

1-(2-benzothiophenyl)cyclohexylamine

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
112726-66-6

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine

Conditions
ConditionsYield
With potassium carbonate 1.) DMF, 60 deg C, 48 h, 2.) DMF, heating, 24 h; Yield given. Multistep reaction;
With potassium carbonate 1) DMF, 60 deg C, 48 h, 2) 60 deg C, 24 h; Yield given. Multistep reaction;
1-(benzo[b]thiophen-2-yl)cyclohexan-1-ol
6774-43-2

1-(benzo[b]thiophen-2-yl)cyclohexan-1-ol

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
112726-66-6

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: NaN3, CF3COOH / CHCl3 / 0 - 20 °C
2: LiAlH4 / tetrahydrofuran; diethyl ether / Ambient temperature
3: 2.) K2CO3 / 1.) DMF, 60 deg C, 48 h, 2.) DMF, heating, 24 h
View Scheme
Multi-step reaction with 3 steps
1: NaN3, CF3CO2H / CHCl3 / 20 °C
2: LiAlH4 / diethyl ether; tetrahydrofuran / 20 °C
3: 2) K2CO3 / 1) DMF, 60 deg C, 48 h, 2) 60 deg C, 24 h
View Scheme
cyclohexanone
108-94-1

cyclohexanone

hydrogen

hydrogen

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
112726-66-6

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) n-BuLi / 1.) Et2O, hexane, RT, 2.) Et2O, hexane, RT
2: NaN3, CF3COOH / CHCl3 / 0 - 20 °C
3: LiAlH4 / tetrahydrofuran; diethyl ether / Ambient temperature
4: 2.) K2CO3 / 1.) DMF, 60 deg C, 48 h, 2.) DMF, heating, 24 h
View Scheme
2-(1-Azido-cyclohexyl)-benzo[b]thiophene
143603-25-2

2-(1-Azido-cyclohexyl)-benzo[b]thiophene

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
112726-66-6

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: LiAlH4 / tetrahydrofuran; diethyl ether / Ambient temperature
2: 2.) K2CO3 / 1.) DMF, 60 deg C, 48 h, 2.) DMF, heating, 24 h
View Scheme
Multi-step reaction with 2 steps
1: LiAlH4 / diethyl ether; tetrahydrofuran / 20 °C
2: 2) K2CO3 / 1) DMF, 60 deg C, 48 h, 2) 60 deg C, 24 h
View Scheme
Benzo[b]thiophene
95-15-8

Benzo[b]thiophene

potassium permanganate

potassium permanganate

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
112726-66-6

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1.) n-BuLi / 1.) Et2O, hexane, RT, 2.) Et2O, hexane, RT
2: NaN3, CF3COOH / CHCl3 / 0 - 20 °C
3: LiAlH4 / tetrahydrofuran; diethyl ether / Ambient temperature
4: 2.) K2CO3 / 1.) DMF, 60 deg C, 48 h, 2.) DMF, heating, 24 h
View Scheme
cyclohexanone
108-94-1

cyclohexanone

oxygen

oxygen

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
112726-66-6

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1) butyllithium / 1) ether, hexane, 2 h, 20 deg C
2: NaN3, CF3CO2H / CHCl3 / 20 °C
3: LiAlH4 / diethyl ether; tetrahydrofuran / 20 °C
4: 2) K2CO3 / 1) DMF, 60 deg C, 48 h, 2) 60 deg C, 24 h
View Scheme
Benzo[b]thiophene
95-15-8

Benzo[b]thiophene

sulfur

sulfur

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
112726-66-6

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine

Conditions
ConditionsYield
Multi-step reaction with 4 steps
1: 1) butyllithium / 1) ether, hexane, 2 h, 20 deg C
2: NaN3, CF3CO2H / CHCl3 / 20 °C
3: LiAlH4 / diethyl ether; tetrahydrofuran / 20 °C
4: 2) K2CO3 / 1) DMF, 60 deg C, 48 h, 2) 60 deg C, 24 h
View Scheme
Benzo[b]thiophene
95-15-8

Benzo[b]thiophene

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
112726-66-6

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 1.) n-BuLi, 2.) iodine / 1.) ether, hexane, -20 deg C, 2.) reflux, 30 min
2: 1.) Mg / 1.) ether, 2.) reflux, 16 h
View Scheme
1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
112726-66-6

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine

A

1-<1-(7-nitro-2-benzothienyl)cyclohexyl>piperidine
143603-50-3

1-<1-(7-nitro-2-benzothienyl)cyclohexyl>piperidine

B

1-<1-(5-nitro-2-benzothienyl)cyclohexyl>piperidine
143603-49-0

1-<1-(5-nitro-2-benzothienyl)cyclohexyl>piperidine

C

1-<1-(4-nitro-2-benzothienyl)cyclohexyl>piperidine
143603-63-8

1-<1-(4-nitro-2-benzothienyl)cyclohexyl>piperidine

Conditions
ConditionsYield
With trifluoroacetic acid; sodium nitrite at 20℃; for 3h;A 20%
B 9%
C 60%
1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
112726-66-6

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine

1-<1-(5-amino-2-benzothienyl)cyclohexyl>piperidine
143603-52-5

1-<1-(5-amino-2-benzothienyl)cyclohexyl>piperidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 9 percent / CF3CO2H, NaNO2 / 3 h / 20 °C
2: conc. HCl, H2 / 10percent Pd/C / methanol / 2 h / 760 Torr
View Scheme
1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
112726-66-6

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine

1-<1-(4-amino-2-benzothienyl)cyclohexyl>piperidine
143603-51-4

1-<1-(4-amino-2-benzothienyl)cyclohexyl>piperidine

Conditions
ConditionsYield
Multi-step reaction with 2 steps
1: 60 percent / CF3CO2H, NaNO2 / 3 h / 20 °C
2: 96 percent / conc. HCl, H2 / 10percent Pd/C / methanol / 2 h / 760 Torr
View Scheme
1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
112726-66-6

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine

1-<1-(4-isothiocyanato-2-benzothienyl)cyclohexyl>piperidine
143603-22-9

1-<1-(4-isothiocyanato-2-benzothienyl)cyclohexyl>piperidine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 60 percent / CF3CO2H, NaNO2 / 3 h / 20 °C
2: 96 percent / conc. HCl, H2 / 10percent Pd/C / methanol / 2 h / 760 Torr
3: 97 percent / sat. aq. NaHCO3, / CHCl3 / 0.17 h / 20 °C
View Scheme
1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine
112726-66-6

1-[1-(2-benzo[b]thienyl)cyclohexyl]piperidine

1-<1-(5-isothiocyanato-2-benzothienyl)cyclohexyl>piperidine
143603-23-0

1-<1-(5-isothiocyanato-2-benzothienyl)cyclohexyl>piperidine

Conditions
ConditionsYield
Multi-step reaction with 3 steps
1: 9 percent / CF3CO2H, NaNO2 / 3 h / 20 °C
2: conc. HCl, H2 / 10percent Pd/C / methanol / 2 h / 760 Torr
3: sat. aq. NaHCO3 / CHCl3 / 10 h / 20 °C
View Scheme

112726-66-6Relevant articles and documents

Synthesis and Biological Evaluation of 1-thienyl)cyclohexyl>piperidine Homologues at Dopamine-Uptake and Phencyclidine- and ?-Binding Sites

He, Xiao-shu,Raymon, Lionel P.,Mattson, Mariena V.,Eldefrawi, Mohyee E.,Costa, Brian R. de

, p. 1188 - 1193 (2007/10/02)

Piperidine and cyclohexyl ring homologues of the high-affinity dopamine (DA) uptake inhibitor 1-thienyl)cyclohexyl>piperidine (BTCP, 3) were each prepared in four steps from the appropriate cycloalkanones.These compounds were tested for their ability to displace BTCP and cocaine and to inhibit DA uptake in rat striatal homogenates.The ratios IC50(cocaine)/IC50(BTCP) ranged from 62 for BTCP to 1.5 for 1-(2-benzothienyl)cyclopentylamine (17); cocaine gave a ratio of 0.6.This indicates that BTCP is the most selective of all the compounds tested for sites labeled by BTCP whereas cocaine is most selective for sites labeled by cocaine.The wide differences in the relative abilities of these compounds to displace BTCP and cocaine suggests that these two radioligands are labeling different sites on the transporter.In general, the compounds structurally related to BTCP exhibited greater selectivity for sites labeled by BTCP.However, several of the BTCP-related derivatives showed greater (compared with BTCP and cocaine) ability to displace cocaine.Most notably, 1-thienyl)cyclohexyl>pyrrolidine (7) exhibited a 3.4-fold greater affinity for these sites compared with BTCP and a 9-fold greater affinity at these sites than cocaine.Most of the BTCP homologues displayed greater ability to inhibit DA uptake in rat forebrain synaptosomes than cocaine.BTCP and 7 were the most potent of all the compounds tested in terms of their ability to inhibit uptake of DA.IC50 ratios for cocaine binding/DA uptake ranged from 0.47 for 1-thienyl)cyclopentyl>homopiperidine (11) to 8.8 for 1-(2-benzothienyl)cyclohexylamine (4).The importance of thisratio remains unclear in terms of identification of potential cocaine antagonists.As for BTCP, all of the compounds tested showed Ki values > 10 000 nM for displacement of TCP from rat brain homogenates.These compounds were able to displace the highly selective ? receptor probe -(+)-pentazocine from guinea pig brain homogenates with Ki values ranging from 125 to 9170 nM.The significance of their ?-binding activity in light of their dopaminergic properties is unclear.The diverse binding properties of these compounds at the DA-uptake site and their spectrum of inhibitory activities for DA uptake identifies them as a useful base for the development of subtype selective probes at this site.These compounds will allow further study of the structure and function of the "cocaine" receptor as well as the development of potential cocaine antagonists.

Preparation and study of derivatives and analogues of the phencyclidine molecule possessing immunosuppressive properties in vitro

Ilagouma, A. T.,Dornand, J.,Liu, C. F.,Zenone, F.,Mani, J. C.,Kamenka, J. M.

, p. 609 - 615 (2007/10/02)

Derivatives and analogues of the phencyclidine molecule (1-phenyl 1-(1-piperidino) cyclohexane or PCP) were prepared to investigate their immunosuppressive potency and to define the physicochemical parameters which may influence this activity recently demonstrated for PCP.Most of the tested molecules are more effective than PCP itself.In spite of lack of quantitative data, the biological activity appears to be dependent upon 3 parameters: conformation, lipophilicity, and the empirical Hammett's parameters.The homogeneous conformations with a high lipophilicity were the most immunosuppressive.Interestingly, such structures appeared to be of weak potency on the PCP receptor in the CNS.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 112726-66-6
  • ©2008 LookChem.com,License:ICP NO.:Zhejiang16009103 complaints:service@lookchem.com
  • [Hangzhou]86-571-87562588,87562561,87562573 Our Legal adviser: Lawyer